Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.81
-0.09 (-0.23%)
Jun 3, 2026, 12:14 PM EDT - Market open
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 129 employees as of March 31, 2026. The number of employees increased by 43 or 50.00% compared to the same quarter last year.
Employees
129
Change
43
Growth
50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,942,930
Market Cap
6.16B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 129 | 43 | 50.00% |
| Dec 31, 2025 | 118 | 41 | 53.25% |
| Sep 30, 2025 | 114 | 39 | 52.00% |
| Jun 30, 2025 | 98 | 26 | 36.11% |
| Mar 31, 2025 | 86 | 9 | 11.69% |
| Dec 31, 2024 | 77 | 1 | 1.32% |
| Sep 30, 2024 | 75 | 0 | - |
| Jun 30, 2024 | 72 | 8 | 12.50% |
| Mar 31, 2024 | 77 | -5 | -6.10% |
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Sep 30, 2023 | 75 | 7 | 10.29% |
| Jun 30, 2023 | 64 | -4 | -5.88% |
| Mar 31, 2023 | 82 | -8 | -8.89% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Sep 30, 2022 | 68 | -2 | -2.86% |
| Jun 30, 2022 | 68 | 23 | 51.11% |
| Mar 31, 2022 | 90 | 45 | 100.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| PTC Therapeutics | 991 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 253 |
CNTA News
- 2 days ago - Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development - PRNewsWire
- 27 days ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 weeks ago - Centessa Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 6 weeks ago - Centessa downgraded to Equal Weight from Overweight at Wells Fargo - TheFly
- 6 weeks ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 7 weeks ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 7 weeks ago - Centessa downgraded to Hold from Buy at Truist - TheFly